Clinical Trial Update: Combined Therapy Using Oxaliplatin and Gemcitabine Chemotherapy, Lenvatinib and PD1 Antibody (JS001) for Patients With Advanced and Unresectable Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating a combination of oxaliplatin and gemcitabine chemotherapy, lenvatinib, and a PD-1 antibody (JS001) for advanced, unresectab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• JS001 (PD-1 inhibitor)
• Lenvatinib (lenvatinib)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Cholangiocarcinoma, Intrahepatic | Phase 2 | Status: UNKNOWN